Hims & Hers Health Inc
NYSE:HIMS

Watchlist Manager
Hims & Hers Health Inc Logo
Hims & Hers Health Inc
NYSE:HIMS
Watchlist
Price: 27.6 USD 3.41% Market Closed
Market Cap: 6B USD
Have any thoughts about
Hims & Hers Health Inc?
Write Note

Wall Street
Price Targets

HIMS Price Targets Summary
Hims & Hers Health Inc

Wall Street analysts forecast HIMS stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HIMS is 22.13 USD with a low forecast of 16.16 USD and a high forecast of 29.4 USD.

Lowest
Price Target
16.16 USD
41% Downside
Average
Price Target
22.13 USD
20% Downside
Highest
Price Target
29.4 USD
7% Upside

HIMS Last Price Targets
Hims & Hers Health Inc

The latest public price target was made on Nov 5, 2024 by Ryan MacDonald from Needham , who expects HIMS stock to rise by 1% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Ryan MacDonald
Needham
28 USD
Upside 1%
1 week ago
Nov 5, 2024
Hims and Hers (HIMS) PT Raised to $28 at Needham
StreetInsider
Korinne Wolfmeyer
Piper Sandler
21 USD
Downside 24%
1 week ago
Nov 5, 2024
Hims and Hers (HIMS) PT Raised to $21 at Piper Sandler
StreetInsider
Michael Cherny
Leerink Partners
26 USD
Downside 6%
2 weeks ago
Oct 29, 2024
Hims and Hers (HIMS) PT Raised to $26 at Leerink Partners
StreetInsider
Michael Cherny
Bank of America Securities
25 USD
Downside 9%
3 weeks ago
Oct 21, 2024
Hims and Hers (HIMS) PT Raised to $25 at BofA Securities
StreetInsider
Michael Cherny
Bank of America Securities
23 USD
Downside 17%
1 month ago
Oct 14, 2024
Hims and Hers (HIMS) PT Raised to $23 at BofA Securities
StreetInsider
Jailendra Singh
Truist Financial
23 USD
Downside 17%
1 month ago
Oct 14, 2024
Truist Securities Reiterates Hold Rating on Hims and Hers (HIMS)
StreetInsider
Allen Lutz
Bank of America Securities
20 USD
Downside 28%
2 months ago
Sep 13, 2024
Hims & Hers price target lowered to $20 from $24 at BofA
TheFly
Daniel Grosslight
Citigroup
20 USD
Downside 28%
2 months ago
Aug 27, 2024
Citi on Hims and Hers (HIMS) Post Lilly (LLY) News: 'Single-dose Zepbound Vials a Shot Across the Bow for the Compounders'
StreetInsider
Glen Santangelo
Jefferies
18 USD
Downside 35%
3 months ago
Aug 7, 2024
Hims and Hers (HIMS) PT Lowered to $18 at Jefferies
StreetInsider
George Hill
Deutsche Bank
23 USD
Downside 17%
3 months ago
Aug 6, 2024
Hims and Hers (HIMS) PT Raised to $23 at Deutsche Bank
StreetInsider
Maria Ripps
Canaccord Genuity
24 USD
Downside 13%
5 months ago
May 22, 2024
Hims and Hers (HIMS) PT Raised to $24 at Canaccord Genuity
StreetInsider
Korinne Wolfmeyer
Piper Sandler
13 USD
Downside 53%
6 months ago
May 7, 2024
Hims and Hers (HIMS) PT Raised to $13 at Piper Sandler
StreetInsider
Jailendra Singh
Truist Financial
13 USD
Downside 53%
6 months ago
May 7, 2024
Hims & Hers Health's Model 'Proving Effective': 2 Analysts Examine Q1 Earnings
Benzinga
George Hill
Deutsche Bank
16 USD
Downside 42%
6 months ago
May 7, 2024
Hims and Hers (HIMS) PT Raised to $16 at Deutsche Bank
StreetInsider
Glen Santangelo
Jefferies
14 USD
Downside 49%
6 months ago
May 7, 2024
Hims and Hers (HIMS) PT Lowered to $14 at Jefferies
StreetInsider
Glen Santangelo
Jefferies
15 USD
Downside 46%
6 months ago
Apr 16, 2024
Jefferies Downgrades Hims and Hers (HIMS) to Hold
StreetInsider
Maria Ripps
Canaccord Genuity
20 USD
Downside 28%
7 months ago
Apr 10, 2024
Canaccord Genuity Starts Hims and Hers (HIMS) at Buy, 'we see a healthy long-term opportunity'
StreetInsider
Show More Price Targets
Show Less Price Targets
Ryan MacDonald
Needham
Price Target 28 USD
Upside/Downside 1%
View Source
Korinne Wolfmeyer
Piper Sandler
Price Target 21 USD
Upside/Downside 24%
View Source
Michael Cherny
Leerink Partners
Price Target 26 USD
Upside/Downside 6%
View Source
Michael Cherny
Bank of America Securities
Price Target 25 USD
Upside/Downside 9%
View Source
Michael Cherny
Bank of America Securities
Price Target 23 USD
Upside/Downside 17%
View Source
Jailendra Singh
Truist Financial
Price Target 23 USD
Upside/Downside 17%
View Source
Allen Lutz
Bank of America Securities
Price Target 20 USD
Upside/Downside 28%
View Source
Daniel Grosslight
Citigroup
Price Target 20 USD
Upside/Downside 28%
View Source
Glen Santangelo
Jefferies
Price Target 18 USD
Upside/Downside 35%
View Source
George Hill
Deutsche Bank
Price Target 23 USD
Upside/Downside 17%
View Source
Maria Ripps
Canaccord Genuity
Price Target 24 USD
Upside/Downside 13%
View Source
Korinne Wolfmeyer
Piper Sandler
Price Target 13 USD
Upside/Downside 53%
View Source
Jailendra Singh
Truist Financial
Price Target 13 USD
Upside/Downside 53%
View Source
George Hill
Deutsche Bank
Price Target 16 USD
Upside/Downside 42%
View Source
Glen Santangelo
Jefferies
Price Target 14 USD
Upside/Downside 49%
View Source
Glen Santangelo
Jefferies
Price Target 15 USD
Upside/Downside 46%
View Source
Maria Ripps
Canaccord Genuity
Price Target 20 USD
Upside/Downside 28%
View Source
Show More Price Targets
Show Less Price Targets
Hims & Hers Health Inc Competitors:
Price Targets
600763
Topchoice Medical Co Inc
6% Downside
INNV
InnovAge Holding Corp
31% Upside
AVAH
Aveanna Healthcare Holdings Inc
18% Downside
PRDA
Prodia Widyahusada Tbk PT
54% Upside
VIJAYA
Vijaya Diagnostic Centre Ltd
11% Downside
AND
Andlauer Healthcare Group Inc
12% Upside
PINC
Premier Inc
14% Downside

Revenue
Forecast

Revenue Estimate
Hims & Hers Health Inc

The compound annual growth rate of Hims & Hers Health Inc's revenue for the next 3 years is 40%.

N/A
Past Growth
40%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Hims & Hers Health Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Hims & Hers Health Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HIMS's stock price target?
Price Target
22.13 USD

According to Wall Street analysts, the average 1-year price target for HIMS is 22.13 USD with a low forecast of 16.16 USD and a high forecast of 29.4 USD.

What is Hims & Hers Health Inc's Revenue forecast?
Projected CAGR
40%

The compound annual growth rate of Hims & Hers Health Inc's revenue for the next 3 years is 40%.

Back to Top